Disulfide-bonded YC18: A membrane-targeting peptide with superior efficacy against Staphylococcus aureus infections.
Fuente:
PubMed
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Artículo científico |
| Lenguaje: | en |
| Publicado: |
Bioorganic chemistry
2026
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1868266114454126592 |
|---|---|
| author | Gao, Jinai Wang, Yi Wang, Wanting Yang, Min Cao, Kaixun Pan, Qi Guo, Ruiyin Lu, Qiumin Zhang, Chengchen Li, Juan Lai, Ren |
| author_facet | Gao, Jinai Wang, Yi Wang, Wanting Yang, Min Cao, Kaixun Pan, Qi Guo, Ruiyin Lu, Qiumin Zhang, Chengchen Li, Juan Lai, Ren Gao, Jinai Wang, Yi Wang, Wanting Yang, Min Cao, Kaixun Pan, Qi Guo, Ruiyin Lu, Qiumin Zhang, Chengchen Li, Juan Lai, Ren |
| collection | PubMed - marine biology |
| contents | Disulfide-bonded YC18: A membrane-targeting peptide with superior efficacy against Staphylococcus aureus infections. Gao, Jinai Wang, Yi Wang, Wanting Yang, Min Cao, Kaixun Pan, Qi Guo, Ruiyin Lu, Qiumin Zhang, Chengchen Li, Juan Lai, Ren Staphylococcus aureus Microbial Sensitivity Tests Anti-Bacterial Agents Disulfides Animals Mice Staphylococcal Infections Structure-Activity Relationship Dose-Response Relationship, Drug Humans Molecular Structure Peptides The escalating crisis of antimicrobial resistance, particularly in Staphylococcus aureus (S. aureus) infections, demands innovative therapeutics beyond conventional antibiotics. Spider venom represents a rich source of bioactive peptides with untapped therapeutic potential. Here, we report YC18, a novel disulfide-stabilized β-hairpin peptide derived from the cDNA library of Chilobrachys liboensis (C. liboensis). This peptide exhibits potent and selective activity against S. aureus, with a minimum inhibitory concentration (MIC) of 6.25 μg/mL. Unlike vancomycin, YC18 exhibits low resistance development even after 35 serial passages of S. aureus, underscoring its clinical potential. Structural prediction revealed that YC18's unique dual-disulfide scaffold (Cys2-Cys15, Cys6-Cys11) confers exceptional stability and efficacy, as validated by peptide analog studies. Mechanistically, YC18 selectively targets phosphatidylglycerol (PG) to disrupt bacterial membranes, a process elucidated through molecular dynamics simulations. With high plasma stability, low cytotoxicity, and efficacy in murine infection models, YC18 emerges as a promising candidate for combating S. aureus infections. |
| format | Artículo científico |
| id | pubmed_41353928 |
| institution | PubMed |
| language | en |
| publishDate | 2026 |
| publisher | Bioorganic chemistry |
| record_format | pubmed |
| spellingShingle | Disulfide-bonded YC18: A membrane-targeting peptide with superior efficacy against Staphylococcus aureus infections. Gao, Jinai Wang, Yi Wang, Wanting Yang, Min Cao, Kaixun Pan, Qi Guo, Ruiyin Lu, Qiumin Zhang, Chengchen Li, Juan Lai, Ren Staphylococcus aureus Microbial Sensitivity Tests Anti-Bacterial Agents Disulfides Animals Mice Staphylococcal Infections Structure-Activity Relationship Dose-Response Relationship, Drug Humans Molecular Structure Peptides Disulfide-bonded YC18: A membrane-targeting peptide with superior efficacy against Staphylococcus aureus infections. Gao, Jinai Wang, Yi Wang, Wanting Yang, Min Cao, Kaixun Pan, Qi Guo, Ruiyin Lu, Qiumin Zhang, Chengchen Li, Juan Lai, Ren Staphylococcus aureus Microbial Sensitivity Tests Anti-Bacterial Agents Disulfides Animals Mice Staphylococcal Infections Structure-Activity Relationship Dose-Response Relationship, Drug Humans Molecular Structure Peptides The escalating crisis of antimicrobial resistance, particularly in Staphylococcus aureus (S. aureus) infections, demands innovative therapeutics beyond conventional antibiotics. Spider venom represents a rich source of bioactive peptides with untapped therapeutic potential. Here, we report YC18, a novel disulfide-stabilized β-hairpin peptide derived from the cDNA library of Chilobrachys liboensis (C. liboensis). This peptide exhibits potent and selective activity against S. aureus, with a minimum inhibitory concentration (MIC) of 6.25 μg/mL. Unlike vancomycin, YC18 exhibits low resistance development even after 35 serial passages of S. aureus, underscoring its clinical potential. Structural prediction revealed that YC18's unique dual-disulfide scaffold (Cys2-Cys15, Cys6-Cys11) confers exceptional stability and efficacy, as validated by peptide analog studies. Mechanistically, YC18 selectively targets phosphatidylglycerol (PG) to disrupt bacterial membranes, a process elucidated through molecular dynamics simulations. With high plasma stability, low cytotoxicity, and efficacy in murine infection models, YC18 emerges as a promising candidate for combating S. aureus infections. |
| title | Disulfide-bonded YC18: A membrane-targeting peptide with superior efficacy against Staphylococcus aureus infections. |
| topic | Staphylococcus aureus Microbial Sensitivity Tests Anti-Bacterial Agents Disulfides Animals Mice Staphylococcal Infections Structure-Activity Relationship Dose-Response Relationship, Drug Humans Molecular Structure Peptides |
| url | https://pubmed.ncbi.nlm.nih.gov/41353928/ |